Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMRN – Amarin Corp ADR

Amarin Corporation plc
AMRN
$9.11
Name : Amarin Corporation plc
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $188,663,536.00
EPSttm : -4
finviz dynamic chart for AMRN
Amarin Corporation plc
$9.11
2.67%
$0.25

Float Short %

0.15

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

-0.48

EPS Last/This Y

0.8

EPS This/Next Y

1.2

Price

9.11

Target Price

13.5

Analyst Recom

4

Performance Q

-17.78

Relative Volume

1.34

Beta

0.64

Ticker: AMRN




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-20AMRN0.43950.071.5219298
2025-03-21AMRN0.45380.070.1319347
2025-03-24AMRN0.46630.040.4113793
2025-03-25AMRN0.45510.050.0014255
2025-03-26AMRN0.46010.050.0114277
2025-03-27AMRN0.4650.050.0314351
2025-03-28AMRN0.44410.050.0014364
2025-03-31AMRN0.44810.050.0014585
2025-04-01AMRN0.440.050.0514576
2025-04-02AMRN0.4350.050.0014618
2025-04-03AMRN0.42430.050.0014620
2025-04-04AMRN0.40.050.0014645
2025-04-07AMRN0.410.050.0014699
2025-04-08AMRN0.42940.050.0314865
2025-04-09AMRN0.45120.050.2414966
2025-04-10AMRN0.45740.050.0314996
2025-04-11AMRN9.110.050.5015073
2025-04-14AMRN9.4450.050.5015272
2025-04-15AMRN9.810.050.0115081
2025-04-16AMRN9.330.050.0715151
2025-04-17AMRN9.180.050.0315281
2025-04-18AMRN9.110.050.0315281
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-20AMRN0.44- - -0.22
2025-03-21AMRN0.46- - -0.16
2025-03-24AMRN0.46-100.0- -0.16
2025-03-25AMRN0.46-100.0- -0.16
2025-03-26AMRN0.46-100.0- -0.16
2025-03-27AMRN0.47-100.0- -0.16
2025-03-28AMRN0.44-100.0- -0.16
2025-03-31AMRN0.45-100.0- -0.16
2025-04-01AMRN0.44-100.0- -0.16
2025-04-02AMRN0.43-100.0- -0.16
2025-04-03AMRN0.42-100.0- -0.16
2025-04-04AMRN0.40-100.0- -0.16
2025-04-07AMRN0.42-100.0- -0.16
2025-04-08AMRN0.43-100.0- -0.16
2025-04-09AMRN0.46-100.0- -0.16
2025-04-10AMRN0.46-100.0- -0.16
2025-04-11AMRN9.18-100.0- -0.16
2025-04-14AMRN9.47-100.0- -3.20
2025-04-15AMRN9.81-100.0- -3.20
2025-04-16AMRN9.33-100.0- -3.20
2025-04-17AMRN9.11-100.0- -3.20
2025-04-18AMRN9.11-100.0- -3.20
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-20AMRN0.0011.174.10
2025-03-21AMRN0.0011.174.10
2025-03-24AMRN0.0011.284.10
2025-03-25AMRN0.0011.284.10
2025-03-26AMRN0.0011.282.64
2025-03-27AMRN0.0011.282.64
2025-03-28AMRN0.0011.282.64
2025-03-31AMRN0.0011.632.64
2025-04-01AMRN0.0011.632.64
2025-04-02AMRN0.0011.632.64
2025-04-03AMRN0.0011.632.64
2025-04-04AMRN0.0011.632.64
2025-04-07AMRN0.0040.402.64
2025-04-08AMRN0.0040.402.64
2025-04-09AMRN0.0040.402.64
2025-04-10AMRN0.0040.402.92
2025-04-11AMRN0.0040.402.92
2025-04-14AMRN0.0000.15
2025-04-15AMRN0.0000
2025-04-16AMRN000
2025-04-17AMRN000.15
2025-04-18AMRN0.0000.15
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.12

Avg. EPS Est. Current Quarter

-0.02

Avg. EPS Est. Next Quarter

-0.6

Insider Transactions

Institutional Transactions

Beta

0.64

Average Sales Estimate Current Quarter

50

Average Sales Estimate Next Quarter

46

Fair Value

Quality Score

43

Growth Score

32

Sentiment Score

54

Actual DrawDown %

79.6

Max Drawdown 5-Year %

Target Price

13.5

P/E

Forward P/E

PEG

P/S

0.82

P/B

0.39

P/Free Cash Flow

EPS

-3.99

Average EPS Est. Cur. Y​

-3.2

EPS Next Y. (Est.)

-2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-35.88

Relative Volume

1.34

Return on Equity vs Sector %

-36.9

Return on Equity vs Industry %

-43.9

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.2

EBIT Estimation

Amarin Corporation plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 275
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading